Effect of synthetic estrogens and estrogen-progestin combinations on the hepatic microsomal enzyme system.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003579:Cytochrome Reductases / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology; D004964:Estriol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D004970:Estrone / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005040:Ethynodiol Diacetate / Q000494:pharmacology; D008297:Male; D008656:Mestranol / Q000494:pharmacology*; D008862:Microsomes, Liver / Q000201:enzymology*; D009640:Norethindrone / Q000494:pharmacology; D009641:Norethynodrel / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D011372:Progestins / Q000494:pharmacology*; D011506:Proteins / Q000378:metabolism; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D004967:Estrogens; D011372:Progestins; D011506:Proteins; D004970:Estrone; D004997:Ethinyl Estradiol; D004958:Estradiol; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D003577:Cytochrome P-450 Enzyme System; D008656:Mestranol; D003579:Cytochrome Reductases; D004964:Estriol; D010424:Pentobarbital; D009640:Norethindrone